• English

Partnership & exhibitor information

All partners will receive the highest recognition for their support of EBJIS.

For more information, please see below. 


There will be other branding opportunitites available than the ones mentioned in the booklet. By booking one of the branding options, you have the golden opportunity to increase your company awareness and brand recognition at the conference.

For further information or to make a booking, please contact the EBJIS Conference Organiser at ebjisconference@cap-partner.eu




At Biocomposites, we are distinct in that our team of specialists is singularly focused on the development of innovative calcium compounds for surgical use.

With over 30 years’ experience and an unrivalled dedication to quality, the products we research, engineer and manufacture are at the forefront of calcium technology. 

We are proud to be driving improved outcomes across a wide range of clinical applications, in musculoskeletal infection, trauma, spine and sports injuries, for surgeons and patients alike.

Please visit www.biocomposites.com for more information.

BONESUPPORT™ sells CERAMENT, synthetic bone substitutes that promote and protect bone healing. There are three CERAMENT products; CERAMENT BONE VOID FILLER, CERAMENT G with gentamicin and CERAMENT V with vancomycin. All three products remodel into bone within 6-12 months, and CERAMENT G and V also elute either gentamicin or vancomycin to provide a high local concentration of antibiotic that protects bone healing.

Our products are used when bone defects cannot heal by themselves, for example in trauma, fracture-related infection, chronic osteomyelitis and diabetic foot osteomyelitis.

Please visit www.bonesupport.com for more information. BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Heraeus Medical stands for delivering value to the patient, the healthcare professional and the healthcare system through innovation and evidence based medicine in Implant Fixation,  Infection Management and regenerative treatments for bone, cartilage and soft tissue. Over the years the company built up extensive experience in the field of therapeutic support for PJI with local antibiotics and is a reliable and committed partner in all aspects that deal with the management of musculoskeletal infections.

Please visit www.heraeus.com for more information. 




A world leader in in vitro diagnostics for 60 years, bioMérieux provides solutions that determine the origin of a disease. World leader in microbiology, specialized in immunoassays, and leading pioneer in the syndromic molecular approach, the Company is committed on major public health issues, such as antimicrobial resistance, sepsis, and respiratory infections.

Our BioFire® Joint Infection Panel detects multiple bacteria, fungi, and antimicrobial resistance genes directly from a single patient sample with results available in about 1 hour.

Please visit www.biomerieux.com for more information.

InfectoPharm is a family-owned company located in Germany. With IV FOSFOMYCIN (product names Fomicyt®, InfectoFos® and Fosfomycin InfectoPharm), InfectoPharm offers a therapeutic option to fight severe infections in a broad indication spectrum. It is an antibiotic of it´s own class with unique product characteristics: unique mode of action, a tissue penetration champion, capable of penetrating tissue with poor accessibility with high bactericidal levels with broad spectrum against Gram positive and - negative pathogens including MDR bacteria.

Please visit en.infectopharm.com/international-partners for more information.


Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. 

Zimmer Biomet will be promoting unique products covering the four pillars of infection management – Prevention, Diagnostics, Therapy, and Re-Implantation.

For more information visit www.zimmerbiomet.eu/en/products-and-solutions/specialties/infection-management.html
Follow us on LinkedIn: www.linkedin.com/company/zimmer-biomet-emea/, and on Twitter: www.twitter.com/zimmerbiomet.



EUROPEAN CELL AND TISSUE BANK, a non-profit association, based in Austria. In compliance with the EU directives, we procure, store, processes and distribute tissue, and offer with OSmycin™, a human bone allograft, impregnated with antibiotics (Vancomycin or Tobramycin). OSmycin™ for simultaneously preventing infection and biofilm while reconstructing of bone defects. 

Please visit www.ectb.eu for more information.


At the intersection of technology and human biology, Bonalive® granules reduces the need for antibiotics in the resolution of chronic bone infections. Bonalive Biomaterials provides patients and surgeons with well-proven and safe bone regenerative products in orthopedics, trauma, spine and septic bone surgery. It's time to heal smarter. #SmartHealing

Please visit www.bonalive.com for more information.

curasan develops and manufactures biomaterials in the field of bone and tissue regeneration. As an industry pioneer, curasan has more than 30 years of innovation experience, represented by a strong portfolio for orthopedic surgery based on proven technologies and great brands like CERASORB® or CERACELL®.

Please visit www.curasan.com for more information.

G-21  is an innovator in the bone cement market for orthopedics and minimally invasive spine surgery bringing strenght to life for every patient.
Commitment, dedication and drive to find modern solutions combined with proprietary patents make the G-21 portfolio unique in the industry. 
The entire product portfolio has been developed in-house and tested through research programs with renowned institutions and universities worldwide.
Located outside Modena, Italy, quality and manufacturing are critical to consistently delivering high-performing cement and accessories to the market in over 45 countries.

Please visit www.g-21.it  for more information

inbiome is dedicated to creating groundbreaking molecular technology that enhances people's well-being and extends their lifespan. Our cutting-edge Molecular Culture® technology provides a rapid and reliable solution by offering meticulously standardized assays, which are CE/IVD marked, enabling the detection of any bacteria in clinical samples within a matter of hours.
Our diverse range of assays surpasses mere identification, enabling the detection of single bacteria as well as complex microbiota. We possess the capability to identify bacteria down to the species level. 
We collaborate closely with esteemed universities and hospitals to explore emerging areas of bacterial diagnostics and advance preventive and predictive healthcare in relation to the microbiome.
Presently, our assay portfolio encompasses two key offerings: Molecular Culture® and Molecular Culture® Microbiota.

Please visit www.inbiome.com for more information.

OSARTIS GmbH is a medical device company located in Germany focusing on the development, registration, production and distribution of medical biomaterials and PMMA bone cements.

Please visit https://osartis.de/en/ for more information.


RESORBA's core competencies lie in the manufacturing and distribution of collagen products and surgical sutures for all surgical disciplines in hospitals and private practices.

Please visit: www.resorba.com

For over 40 years Tecres has developed and manufactured PMMA bone cements for orthopaedics and devices for supporting the treatment of PJI. Cemex bone cements and Spacer, the unique temporary antibiotics-loaded prostheses for two-stage septic revision, are successfully sold worldwide. These products are available also in the combination Vancomycin-Gentamicin. We are active also in the field of spinal surgery and neurosurgery.

Please visit www.tecres.com for more information